Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 3Active not recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Cognitive Dysfunction 2Breast Neoplasms 2Depression 1Breast Cancer Survivors 1

Interventions

Paclitaxel 62Letrozole 55Fulvestrant 55Trastuzumab 50palbociclib 41pembrolizumab 37Cyclophosphamide 37Carboplatin 37Anastrozole 37pertuzumab 35exemestane 25Tamoxifen 24Capecitabine 24ribociclib 23abemaciclib 23Radiotherapy 21Docetaxel 21olaparib 20Doxorubicin 20Magnetic Resonance Spectroscopy 19trastuzumab deruxtecan 17Surveys and Questionnaires 17durvalumab 16Epirubicin 16Specimen Handling 14Exercise 14130-nm albumin-bound paclitaxel 14Taxes 13Alpelisib 13Goserelin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Breast Neoplasms × Transcranial Direct Current Stimulation × Clear all
NCT07083518 2025-07-24

Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer Survivors

Anhui Medical University

Phase NA Active not recruiting
60 enrolled
Breast

Breast Neoplasms, Cognitive Dysfunction

NCT06053775 2025-07-20

ONCODEP

University of Santiago de Compostela

Phase NA Active not recruiting
82 enrolled
Breast

Breast Neoplasms, Depression, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡